心不全POCおよびLOCデバイスの2030年までの世界市場予測：検査タイプ、技術、エンドユーザー、地域別に分析

Stratistics MRCによると、世界の心不全POCおよびLOCデバイス市場は2023年に9,762万米ドルを占め、2030年には3億2,794万米ドルに達すると予測され、予測期間中のCAGRは18.9%で成長する見込みです。

ポイントオブケア（POC）およびラボオンチップ（LOC）として知られるデバイスは、心不全治療において革命的な存在となっています。ヘルスケアプロバイダーは、これらのポータブルで迅速な診断技術を使ってその場で検査を行うことができ、患者の心臓の健康状態を迅速に把握することができます。患者のベッドサイドやプライマリケアの現場で迅速かつ効果的な診断を提供するPOC機器には、ハンドヘルド超音波診断装置、ポータブル心臓バイオマーカー分析装置、小型化ラボオンチッププラットフォームなどがあります。

2018年のCDC報告によると、毎年約655,000人の米国人が心臓病で亡くなっており、米国における主要な死因となっている（4人に1人が死亡）。

高まる心不全率

POCおよびLOCデバイスの市場は、主に高齢化、座りがちなライフスタイル、心血管危険因子の負担の増大に関連する心不全の発生率の上昇によって牽引されています。さらに、世界的に心不全の有病率が増加しており、心機能を迅速かつ正確に評価し、迅速かつ効率的な治療計画をサポートする診断機器の必要性が高まっています。

予算の制約とアクセシビリティ

POCおよびLOC機器に関連する経済的な制約には、初期取得費用だけでなく、消耗品、メンテナンス、校正などの継続的な支出も含まれます。さらに、患者もヘルスケア施設も、特に資源が限られている環境では、手頃な価格であることに懸念を抱いています。これらの高度な診断ツールには高額な初期費用がかかるため、広く採用されず、アクセシビリティが制限され、費用対効果の高いヘルスケアの提供に影響を及ぼす可能性があります。

診断専門知識の拡大

POCやLOC機器が提供する診断能力を向上させる機会は数多くあります。特にバイオセンサー、マイクロ流体工学、ナノテクノロジーなどの領域における持続的な技術進歩は、当該装置の感度と特異性を高める可能性を提供しています。さらに、医療従事者は、多重化検査と新規バイオマーカーの統合の進歩により、心血管系の健康についてより深く包括的な理解を得ることができるようになった。

強力な市場競争

POCおよびLOC機器市場は競争が激しく、価格圧力、市場の飽和、製品の差別化の難しさなどのリスクがあります。競争圧力は、新規参入や継続的な技術進歩によって高まっています。さらに、競争力を維持するために、企業は研究開発への投資を行い、効果的なマーケティング戦略を実践し、市場ポジションを維持し成長を続けるために独自の価値提案の開発に集中する必要があります。

COVID-19の影響：

COVID-19の流行は、医療診断薬、特にPOC（ポイント・オブ・ケア）およびLOC（ラボオンチップ）機器の市場に大きな影響を与えました。特にCOVID-19の診断において、迅速かつ分散化された検査ソリューションが急務となったため、POCおよびLOCデバイスの需要が急増しました。このような技術的進歩は、検査へのアクセス性を向上させ、ポイント・オブ・ケアでの迅速な結果を促進する上で不可欠です。一方、パンデミックは、ヘルスケア資源の配分の変化、競争の激化、サプライチェーンの混乱といった困難ももたらしました。さらに、パンデミックの管理は技術革新に拍車をかけ、柔軟で分散化された医療システムにおいてPOCおよびLOCデバイスが果たす重要な役割を浮き彫りにしたため、パンデミック後の市場の今後の方向性に影響を与えると思われます。

予測期間中、ゲノム検査セグメントが最大になる見込み

心不全POCおよびLOCデバイス市場で最大のシェアを占めると予想されるセグメントは、ゲノム検査です。ゲノム検査の一環として人のDNAが分析され、遺伝子変異、突然変異、疾患素因が発見されます。この分野は、薬理ゲノミクス、腫瘍学、希少遺伝性疾患、個別化医療など幅広い用途があるため、知名度が高まっています。病気の診断、治療、リスクの評価にはゲノム検査が不可欠です。その結果、より専門的で効率的なヘルスケア介入が可能になります。さらに、ゲノム検査は、シーケンシング技術の継続的な向上と、様々な疾患の遺伝的原因に関する知識の増加により、ますます普及し、分子診断分野における主要なプレーヤーとして認識されるようになってきています。

予測期間中、ホームケア分野のCAGRが最も高くなると予想される

心不全POCおよびLOCデバイス市場では、在宅ケア分野が最も高いCAGRで成長しています。在宅ケアサービスを受ける患者は、快適な自宅で医療ケア、監督、サポートを受ける。高齢化、患者中心の個別ケアへの要望、遠隔モニタリング技術の発展など、多くの要因が在宅ケアの需要増加に寄与しています。患者に利便性を提供するだけでなく、在宅ケア・サービスは入院を最小限に抑えることでヘルスケア・コストを削減します。さらに、COVID-19の大流行により、対面診療に代わる、より危険の少ない医療を求める人々が増え、在宅医療サービスの利用が加速しています。

最大のシェアを持つ地域

心不全POCおよびLOCデバイス市場は北米地域で最大のシェアを占めると予測されています。これは、高いヘルスケア支出、洗練されたヘルスケアインフラ、強固な規制基盤、研究開発の重視といった要素によるものです。特に米国はヘルスケア産業が盛んで、この地域の優位性に大きく寄与しています。さらに北米は、ヘルスケアへのアクセスのしやすさ、技術革新、高齢化社会への注力から利益を得ています。

CAGRが最も高い地域：

心不全POCおよびLOCデバイス市場は、アジア太平洋地域で最も高いCAGRで成長しています。医療意識の高まり、可処分所得の増加、ヘルスケアインフラの整備、高齢化と人口増加が、この爆発的成長を促す要因の一部です。中国やインドなどのAPAC諸国では、政府の奨励的な取り組みとともに、ヘルスケア・サービスやテクノロジーへの多額の投資が行われています。さらに、最先端の医療に対する需要と慢性疾患の増加も、アジア太平洋ヘルスケア市場の力強い成長を支えています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 技術分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の心不全POCおよびLOCデバイス市場：検査タイプ別

• プロテオミクス検査
• メタボローム検査
• ゲノム検査
• その他の検査タイプ

第6章 世界の心不全POCおよびLOCデバイス市場：技術別

• マイクロ流体工学
• アレイベースシステム
• その他の技術

第7章 世界の心不全POCおよびLOCデバイス市場：エンドユーザー別

• クリニックと病院
• ホームケア
• 介護付きヘルスケア施設
• ラボ
• 専門センター
• その他のエンドユーザー

第8章 世界の心不全POCおよびLOCデバイス市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• Instrumentation Laboratory Company
• F. Hoffmann-La Roche Ltd
• Abaxis, Inc.
• Jant Pharmacal Corporation
• Danaher Corporation
• Siemens Healthineers
• Trinity Biotech
• Quidel Corporation
• Abbott
• bioMerieux S.A

List of Tables

• Table 1 Global Heart Failure POC And LOC Devices Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
• Table 3 Global Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
• Table 4 Global Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
• Table 5 Global Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
• Table 6 Global Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
• Table 7 Global Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
• Table 8 Global Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
• Table 9 Global Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
• Table 10 Global Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 11 Global Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 12 Global Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
• Table 13 Global Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
• Table 14 Global Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
• Table 15 Global Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
• Table 16 Global Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
• Table 17 Global Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 18 North America Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 19 North America Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
• Table 20 North America Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
• Table 21 North America Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
• Table 22 North America Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
• Table 23 North America Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
• Table 24 North America Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
• Table 25 North America Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
• Table 26 North America Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
• Table 27 North America Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 28 North America Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 29 North America Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
• Table 30 North America Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
• Table 31 North America Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
• Table 32 North America Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
• Table 33 North America Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
• Table 34 North America Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 35 Europe Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 36 Europe Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
• Table 37 Europe Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
• Table 38 Europe Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
• Table 39 Europe Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
• Table 40 Europe Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
• Table 41 Europe Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
• Table 42 Europe Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
• Table 43 Europe Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
• Table 44 Europe Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 45 Europe Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 46 Europe Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
• Table 47 Europe Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
• Table 48 Europe Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
• Table 49 Europe Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
• Table 50 Europe Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
• Table 51 Europe Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 52 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 53 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
• Table 54 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
• Table 55 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
• Table 56 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
• Table 57 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
• Table 58 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
• Table 59 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
• Table 60 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
• Table 61 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 62 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 63 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
• Table 64 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
• Table 65 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
• Table 66 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
• Table 67 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
• Table 68 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 69 South America Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 70 South America Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
• Table 71 South America Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
• Table 72 South America Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
• Table 73 South America Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
• Table 74 South America Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
• Table 75 South America Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
• Table 76 South America Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
• Table 77 South America Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
• Table 78 South America Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 79 South America Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 80 South America Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
• Table 81 South America Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
• Table 82 South America Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
• Table 83 South America Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
• Table 84 South America Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
• Table 85 South America Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 86 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 87 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
• Table 88 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
• Table 89 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
• Table 90 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
• Table 91 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
• Table 92 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
• Table 93 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
• Table 94 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
• Table 95 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 96 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 97 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
• Table 98 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
• Table 99 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
• Table 100 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
• Table 101 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
• Table 102 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Heart Failure POC and LOC Devices Market is accounted for $97.62 million in 2023 and is expected to reach $327.94 million by 2030 growing at a CAGR of 18.9% during the forecast period. Devices known as point-of-care (POC) and lab-on-a-chip (LOC) have become revolutionary in the treatment of heart failure. Healthcare providers can perform on-the-spot testing with these portable, rapid diagnostic technologies, giving them quick insights into a patient's cardiac health. POC devices, which provide quick and effective diagnostics at the patient's bedside or in primary care settings, include handheld ultrasound devices, portable cardiac biomarker analyzers, and miniaturized lab-on-a-chip platforms.

According to a CDC report from 2018, approximately 655,000 Americans pass away from heart disease each year, making it the leading cause of death in the US (1 in every 4 deaths).

Market Dynamics:

Driver:

Growing heart failure rates

The market for POC and LOC devices is primarily driven by the rising incidence of heart failure, which is linked to aging populations, sedentary lifestyles, and the mounting burden of cardiovascular risk factors. Additionally, globally, the prevalence of heart failure is increasing, which raises the need for diagnostic instruments that can quickly and accurately evaluate cardiac function and support prompt and efficient treatment plans.

Restraint:

Budgetary restrictions and accessibility

The financial limitations pertaining to POC and LOC devices comprise not only the initial acquisition costs but also continuous expenditures like consumables, maintenance, and calibration. Furthermore, patients and healthcare facilities alike are concerned about affordability, especially in environments with limited resources. These advanced diagnostic tools come with a high upfront cost, which could prevent them from being widely adopted, restrict accessibility, and affect how cost-effectively healthcare is delivered.

Opportunity:

Extension of diagnostic expertise

There are numerous opportunities to increase the diagnostic capabilities that POC and LOC devices offer. Sustained technological progress, specifically in domains like biosensors, micro fluidics, and nanotechnology, offers prospects for augmenting the sensitivity and specificity of said apparatus. Moreover, healthcare practitioners can now obtain a deeper and more comprehensive understanding of cardiovascular health thanks to advancements in multiplexed testing and the integration of novel biomarkers.

Threat:

Strong market rivalry

The POC and LOC device market is highly competitive, which poses risks like price pressure, market saturation, and difficulty differentiating products. The pressure to compete is increased by new entrants and ongoing technological advancements. Furthermore, in order to stay competitive, businesses need to make investments in R&D, put effective marketing strategies into practice, and concentrate on developing distinctive value propositions in order to hold onto their market positions and continue growing.

COVID-19 Impact:

The COVID-19 pandemic has had a significant effect on the market for medical diagnostics, particularly point-of-care (POC) and lab-on-a-chip (LOC) devices. Demand for POC and LOC devices has surged due to the pressing need for quick and decentralized testing solutions, especially in the diagnosis of COVID-19. These technological advancements have been essential in improving test accessibility and facilitating prompt results at the point of care. On the other hand, the pandemic has also brought about difficulties like changes in the distribution of healthcare resources, heightened competition, and supply chain disruptions. Moreover, the management of the pandemic has spurred innovation and highlighted the critical role POC and LOC devices play in flexible, decentralized healthcare systems, which will impact the market's future direction in the aftermath of the pandemic.

The Genomic Testing segment is expected to be the largest during the forecast period

The segment of the heart failure POC and LOC devices market that is expected to hold the largest share is genomic testing. A person's DNA is analyzed as part of a genomic test to find genetic variants, mutations, and disease predispositions. The broad applications of this segment in pharmacogenomics, oncology, rare genetic disorders, and personalized medicine have made it more well-known. In order to diagnose, treat, and evaluate disease risk, genomic testing is essential. This results in more specialized and efficient healthcare interventions. Additionally, genomic testing is becoming increasingly popular and is becoming recognized as a major player in the field of molecular diagnostics due to the ongoing improvements in sequencing technologies and the growing knowledge of the genetic causes of various diseases.

The Home Care segment is expected to have the highest CAGR during the forecast period

In the market for heart failure POC and LOC devices, the home care segment is growing at the highest CAGR. Patients receiving home care services receive medical attention, supervision, and support in the comfort of their own homes. A number of factors, such as an aging population, a desire for individualized and patient-centered care, and developments in remote monitoring technologies, have contributed to the rise in demand for home care. In addition to providing patients with convenience, home care services lower healthcare costs by minimizing hospital stays. Moreover, the COVID-19 pandemic has expedited the uptake of home care services as individuals pursue less hazardous substitutes for in-person medical consultations.

Region with largest share:

It is projected that the heart failure POC and LOC device market will have the largest share in the North American region. This is ascribed to elements like high healthcare spending, sophisticated healthcare infrastructure, a solid regulatory base, and a strong emphasis on R&D. With a large healthcare industry footprint, the United States in particular is a major factor contributing to the region's dominance. Furthermore, North America gains from a focus on healthcare accessibility, technological innovation, and an aging population.

Region with highest CAGR:

The market for heart failure POC and LOC devices is growing at the highest CAGR in the Asia-Pacific region. Growing healthcare awareness, rising disposable incomes, growing healthcare infrastructure, and an aging and sizable population are some of the factors driving this explosive growth. Significant investments in healthcare services and technology are being made in APAC nations like China and India, along with encouraging government initiatives. Additionally, the demand for cutting-edge medical treatments and the rising incidence of chronic diseases both support the strong growth in the Asia-Pacific healthcare market.

Key players in the market:

Some of the key players in Heart Failure POC and LOC Devices market include Instrumentation Laboratory Company, F. Hoffmann-La Roche Ltd, Abaxis, Inc., Jant Pharmacal Corporation, Danaher Corporation, Siemens Healthineers, Trinity Biotech, Quidel Corporation, Abbott and bioMerieux S.A.

Key Developments:

In December 2023, Roche announced the entry into a definitive merger agreement to acquire Carmot Therapeutics, Inc., a privately owned US company based in Berkeley, California. Carmot's R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat obesity in patients with and without diabetes, as well as a number of preclinical programs.

In December 2023, Danaher Corp., a global life sciences and diagnostics provider based in Washington D.C., has completed its $5.7 billion acquisition of Abcam plc, a supplier of protein research tools for life sciences based in Cambridge, England. Abcam has become an indirect wholly owned subsidiary of Danaher. Danaher's Life Sciences businesses provide tools and technologies to support the advancement of pharmaceuticals and biopharmaceuticals.

In November 2023, Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.

Test Types Covered:

• Proteomic Testing
• Metabolomic Testing
• Genomic Testing
• Other Test Types

Technologies Covered:

• Microfluidics
• Array-based Systems
• Other Technologies

End Users Covered:

• Clinics & Hospitals
• Home Care
• Assisted Living Healthcare Facilities
• Laboratory
• Specialty Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Technology Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Heart Failure POC And LOC Devices Market, By Test Type

• 5.1 Introduction
• 5.2 Proteomic Testing
• 5.3 Metabolomic Testing
• 5.4 Genomic Testing
• 5.5 Other Test Types

6 Global Heart Failure POC And LOC Devices Market, By Technology

• 6.1 Introduction
• 6.2 Microfluidics
• 6.3 Array-based Systems
• 6.4 Other Technologies

7 Global Heart Failure POC And LOC Devices Market, By End User

• 7.1 Introduction
• 7.2 Clinics & Hospitals
• 7.3 Home Care
• 7.4 Assisted Living Healthcare Facilities
• 7.5 Laboratory
• 7.6 Specialty Centers
• 7.7 Other End Users

8 Global Heart Failure POC And LOC Devices Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Instrumentation Laboratory Company
• 10.2 F. Hoffmann-La Roche Ltd
• 10.3 Abaxis, Inc.
• 10.4 Jant Pharmacal Corporation
• 10.5 Danaher Corporation
• 10.6 Siemens Healthineers
• 10.7 Trinity Biotech
• 10.8 Quidel Corporation
• 10.9 Abbott
• 10.10 bioMerieux S.A